Dr. Lisa M. Bateman, MD

Dr. Bateman practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Bateman's NPI, 1639184161, was assigned on July 31, 2006. Dr. Bateman graduated from Dalhousie University Faculty of Medicine in 1995. Dr. Bateman holds California license A73384.

Dr. Bateman's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Bateman's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Bateman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bateman practices. Vendor and product names are available with a free account.

Neurology is Dr. Bateman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bateman is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bateman's licenses on file in 2 states: California and New York.

Dmand AI lists epilepsy and seizures among the conditions Dr. Bateman treats.

CMS data shows 585 Medicare services from Dr. Bateman across 7 procedure codes in 2024, for 194 Medicare patients. Medicare paid $44,572 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Bateman in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bateman's median patient age at 53, with 54% women.

In 2024, Dr. Bateman wrote 113 Medicare Part D claims for 14 patients. 53% of them were for generic drugs. CMS names the drug for 57 of them, across 3 drugs with 11 or more claims each, at $33,727 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bateman for performance year 2024, reported as part of a group. Dr. Bateman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bateman as offering telehealth.

Dmand AI links 67 papers to Dr. Bateman, published from 2008 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Electroencephalography, Seizures and Epilepsy. Dr. Bateman has published most often in Epilepsia. Dr. Bateman's most frequent co-authors are Samden Dorjee Lhatoo, MD, Guy Mead McKhann, MD and Maromi Nei, MD.

Dmand AI links Dr. Bateman to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 7 general payments to Dr. Bateman from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Supernus Pharmaceuticals, Inc. paid the most, $209.

Dmand AI lists 1 award for Dr. Bateman, most recently CMS Stage 1 EHR in 2011.

Dr. Bateman graduated from Dalhousie University Faculty of Medicine in 1995.

Dr. Bateman is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.